Graph 1 - Ibrutinib to R-CHOP chemotherapy (IMAGE)

NIH/National Cancer Institute

Graph 1 - Ibrutinib to R-CHOP chemotherapy

Caption

The addition of ibrutinib to R-CHOP chemotherapy improved overall survival among trial participants aged 60 and younger who had non-GCB diffuse large B-cell lymphoma of either the MCD or N1 subtype

Credit

National Institute of Health (NCI)

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.